A retrospective, observational study of efficacy and safety of elbasvir/grazoprevir in chronic Hepatitis C infected patients
Latest Information Update: 01 Jan 2021
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C; Liver cirrhosis
- Focus Adverse reactions; Therapeutic Use
- 01 Jan 2021 New trial record